Pharmaceutical Company CEO Developing $100 Alternative To EpiPen After 'Shameful' Price Hike
September 4, 2016
Mark Baum, CEO of Imprimis Pharmaceuticals who previously came out with a $1 alternative to Martin Shkreli's AIDS drug after 5000% price hike, is now going to take on Mylan and is plotting to offer a $100 EpiPen alternative.
Mark Baum / Imprimis Pharmceuticals
Baum believes the relentless EpiPen price hikes are "shameful" and plans to have a compounded version of the allergy treatment by the end of the year.
"I don't need to make $19 million a year," Baum said, referring to the big pay package Mylan's CEO Heather Bresch took home last year.
"Tonight when I go home I'm going to eat a nice piece of fish and the fish I eat isn't any better or worse than what she is going to eat."
Click Here For The Most Popular On Sunny Skyz
Couple Rescues Prairie Dog From Their Dog's Mouth, Then Decides To Adopt It
Ohio Man Makes Waves With His Fully Functioning Hot Dog Boat
Teacher’s Final Wish: Backpacks For Students In Need Fill The Aisles At Her Funeral
Why Hope Is The Key To A Meaningful Life, Backed By New Research
These Are The Movie Scenes People Say Are Absolutely Flawless
Judge Waives Parking Fines So Dad Can Keep Supporting Son’s Space Dreams
Every Day, This Golden Retriever Leaps Into The Pig Pen To Play With The Piglets
Dog Saves His Best Friend's Life In Incredible Moment Caught On Video
Woman Tries To Help Bird, Then This Happened... And We Can't Stop Laughing
Newborn Baby Has Sweet Conversation With Dad While Lying On Mom’s Face
Sassy Pig Throws Hilarious Tantrum, Slams Door And Gives Mom Silent Treatment
